做多

Cadila Healthcare: Fibonacci Extension

240
All levels are marked in the chart only.

Cadila Healthcare can begin a new bull run on technical levels......analysis is also backed by news of Virafin(an antiviral produced by Cadila Healthcare) being given emergency approval for treatment of moderate COVID-19 patients.

Volume has also increased drastically.

Cadila has also given closing above a trendline which was previously acting as resistance for the price to move up.

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。